T1	Person 0 8	Children
T2	Condition 52 71	developmental delay
T3	Condition 75 111	inability to communicate the effects
T4	Condition 118 135	allergic reaction
R1	AND Arg1:T3 Arg2:T4	
T5	Qualifier 137 147	non-verbal
R2	Has_qualifier Arg1:T3 Arg2:T5	
*	OR T2 T3
T6	Condition 155 171	contraindication
T7	Procedure 175 190	allergy testing
R3	AND Arg1:T6 Arg2:T7	
T8	Condition 241 265	severe allergic reaction
T9	Procedure 269 279	skin tests
R4	AND Arg1:T8 Arg2:T9	
T10	Observation 228 235	history
R5	Has_temporal Arg1:T8 Arg2:T10	
T11	Condition 283 294	anaphylaxis
T12	Temporal 295 316	in the past six weeks
R6	Has_temporal Arg1:T11 Arg2:T12	
T13	Condition 319 328	pregnancy
T14	Drug 346 359	antihistamine
T15	Temporal 360 382	in the past three days
T16	Drug 394 409	diphenhydramine
T17	Drug 411 419	Benadryl
T18	Drug 423 433	cetirizine
T19	Drug 435 441	Zyrtec
T20	Drug 445 455	loratadine
T21	Drug 457 465	Claritin
T22	Drug 469 481	fexofenadine
T23	Drug 483 490	Allegra
T24	Drug 494 508	levocetirizine
T25	Drug 510 515	Xyzal
T26	Drug 523 536	desloratadine
T27	Drug 538 546	Clarinex
R7	Subsumes Arg1:T16 Arg2:T17	
R8	Subsumes Arg1:T18 Arg2:T19	
R9	Subsumes Arg1:T20 Arg2:T21	
R10	Subsumes Arg1:T22 Arg2:T23	
R11	Subsumes Arg1:T24 Arg2:T25	
R12	Subsumes Arg1:T26 Arg2:T27	
*	OR T16 T18 T20 T22 T24 T26
T28	Scope 394 548	diphenhydramine (Benadryl®), cetirizine (Zyrtec®), loratadine (Claritin®), fexofenadine (Allegra®), levocetirizine (Xyzal®), and desloratadine (Clarinex®)
R13	Has_temporal Arg1:T14 Arg2:T15	
R14	Subsumes Arg1:T14 Arg2:T28	
T29	Drug 605 626	beta blocker medicine
T30	Condition 631 649	cardiac conditions
T31	Condition 651 670	high blood pressure
T32	Condition 672 690	migraine headaches
T33	Condition 709 717	glaucoma
T34	Drug 695 704	eye drops
T35	Drug 724 735	propranolol
T36	Drug 737 747	metoprolol
T37	Drug 749 757	atenolol
T38	Drug 762 770	Timoptic
T39	Drug 776 784	Betoptic
T40	Drug 786 795	eye drops
R15	Subsumes Arg1:T40 Arg2:T39	
R16	AND Arg1:T33 Arg2:T34	
*	OR T30 T31 T32
T41	Scope 631 690	cardiac conditions, high blood pressure, migraine headaches
R17	AND Arg1:T41 Arg2:T29	
*	OR T35 T36 T37 T38 T40
T42	Scope 724 795	propranolol, metoprolol, atenolol and Timoptic®, or Betoptic® eye drops
R18	Subsumes Arg1:T34 Arg2:T42	
*	OR T41 T33
T43	Person 799 807	Children
T44	Visit 827 830	PED
T45	Condition 838 842	rash
T46	Condition 844 852	vomiting
T47	Condition 864 879	asthma symptoms
T48	Condition 890 898	coughing
T49	Condition 900 908	wheezing
T50	Condition 912 930	breathing problems
*	OR T49 T50 T48
T51	Scope 890 930	coughing, wheezing or breathing problems
R19	Subsumes Arg1:T47 Arg2:T51	
*	OR T46 T47 T45
T52	Temporal 856 863	current
R20	Has_temporal Arg1:T47 Arg2:T52	
T53	Non-query-able 1014 1211	Patients being admitted to the hospital or those who are deemed too acutely ill for participation (triage level 1 or 2 or as determined by the ED patient care team) will be excluded from the study.
T54	Observation 1254 1274	non-English speaking
T55	Non-representable 1285 1368	However, in subsequent studies we will include the non-English speaking population.
T56	Observation 1387 1405	wards of the state
T57	Observation 1410 1421	foster care
T58	Observation 1425 1439	police custody
T59	Observation 1443 1452	detention
*	OR T56 T57 T58 T59
T60	Condition 1490 1505	basal condition
T61	Condition 1507 1513	trauma
T62	Condition 1515 1524	infection
T63	Condition 1526 1541	minor accidents
*	OR T61 T62 T63
T64	Scope 1507 1541	trauma, infection, minor accidents
R21	Subsumes Arg1:T60 Arg2:T64	
